Stock ILIU INTERLEUKIN GENETICS, INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Interleukin Genetics, Inc

Equities

ILIU

US4587381017

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for Interleukin Genetics, Inc

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Interleukin Genetics Files Form 15
GL
Interleukin Genetics Files Form 25
GL
Interleukin Genetics To Explore Strategic Alternatives, Reduce Workforce
GL
Interleukin Genetics Reports First Quarter 2017 Financial Results
GL
Interleukin Genetics Reports Fourth Quarter and Year-End 2016 Financial Results
GL
Interleukin-1 Genotypes Are Predictive of Cardiovascular Events in Patients With Elevated Lipoprotein (a)
GL
Interleukin Genetics Signs Second Employer Agreement in Pittsburgh Region
GL
Interleukin Genetics Establishes Partnership with Greater Philadelphia Business Coalition on Health
GL
Interleukin Genetics Deploys ILUSTRA™ Inflammation Management Program with mPulse Mobile Employees
GL
Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship to Bring the ILUSTRA™ Inflammation Management Program to Pittsburgh Area Employers
GL
Interleukin Genetics Launches The ILUSTRA™ Inflammation Management Program
GL
Interleukin Genetics Cites Role in Key Antisense Drug Trial Published in The Lancet
GL
Interleukin-1 Genetic Variations Influence Obesity Effect in Periodontal Disease Progression
GL
Interleukin Genetics Reports Second Quarter 2016 Financial Results
GL
Interleukin Genetics Announces Conference Call to Discuss Second Quarter 2016 Financial Results
GL
Interleukin Genetics Strengthens Commercial Leadership with Key Appointments
GL
Interleukin Genetics Announces Conference Call to Discuss First Quarter 2016 Financial Results
GL
Genetic Stratification of Drug Response in IL-1 Implicated Eye Diseases
GL
Interleukin Genetics Receives Notice of Allowance for United States Patent for PerioPredict® Genetic Risk Test
GL
PerioPredict® Genetic Risk Test Incorporated into Freedom Dental Plan
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ILIU Stock
  4. News Interleukin Genetics, Inc